Cargando…
Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown
The coronavirus disease 2019 (COVID-19) lockdown dramatically changed people’s lifestyles. Diet, physical activity, and the PNPLA3 gene are known risk factors for non-alcoholic fatty liver disease (NAFLD). Aim: To evaluate changes in metabolic and hepatic disease in NAFLD patients after the COVID-19...
Autores principales: | Cinque, Felice, Cespiati, Annalisa, Lombardi, Rosa, Costantino, Andrea, Maffi, Gabriele, Alletto, Francesca, Colavolpe, Lucia, Francione, Paolo, Oberti, Giovanna, Fatta, Erika, Bertelli, Cristina, Sigon, Giordano, Dongiovanni, Paola, Vecchi, Maurizio, Fargion, Silvia, Fracanzani, Anna Ludovica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838646/ https://www.ncbi.nlm.nih.gov/pubmed/35276911 http://dx.doi.org/10.3390/nu14030556 |
Ejemplares similares
-
Impact of deterioration of lifestyle and PNPLA3 genotype in NALFD patients during COVID-19 lockdown
por: Cinque, F., et al.
Publicado: (2022) -
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
por: Cespiati, Annalisa, et al.
Publicado: (2023) -
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
por: Cespiati, Annalisa, et al.
Publicado: (2022) -
Nutritional and Lifestyle Therapy for NAFLD in People with HIV
por: Cinque, Felice, et al.
Publicado: (2023) -
The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value
por: Paolini, Erika, et al.
Publicado: (2023)